Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 21. November 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9157  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 183133  
   
Prognostic utility of preoperative NLR, PLR, SII in penile cancer: A National Cohort Study.
Urol Oncol
Sugrue DD, Eddershaw C, Ryan F, Kuar I, Chaoimh DN, Chinneide EN, Teo MY, Davis NF, Cullen IM.
PMID: 43064572 [PubMed - as supplied by publisher]


Re: Stereotactic Body Radiotherapy Versus Moderately Hypofractionated IMRT for Localized Intermediate-risk Prostate Cancer: A Randomized Clinical Trial.
Eur Urol
Kishan AU, Samala SK, Nagar H.
PMID: 43064549 [PubMed - as supplied by publisher]


Re: Anke Richters, Marinde J. G. Bond, Hans M. Westgeest, et al. Development and External Validation of a New Prognostic Model for Metastatic Clear Cell Renal Cell Carcinoma: A Preregistered Analysis Using Data from Randomised Clinical Trials in the Checkpoint Inhibitor Era. Lancet Oncol 2026;27:1295-303.
Eur Urol
Massari F, Rosellini M, Santoni M, Mollica V.
PMID: 43064548 [PubMed - as supplied by publisher]


Prostate and pelvic nodal stereotactic body radiotherapy (SBRT) versus prostate-only SBRT for high-risk, localised prostate cancer (PACE-NODES): early adverse event results from an international, open-label, phase 3, randomised controlled trial.
Lancet Oncol
Pathmanathan A, Jain S, Cafferty FH, Leaning D, Chan A, Venkitaraman R, Varughese M, Panades M, Ward T, Tree A, Syndikus I, Staffurth J, Song YP, Das P, McGrane J, Pugh J, Naismith O, Murthy V, McGarry CK, McBride K, Kelly P, Hoskin P, Hallett J, Dewan M, Clees-Baron H, Choudhury A, Burnett S, Brown S, Hall E, van As N.
PMID: 43063962 [PubMed - as supplied by publisher]


Metformin use and all-cause and cause-specific mortality in patients with kidney cancer: a nationwide Korean cohort study.
Cancer Treat Res Commun
Sim Y, Jung G, Shim M, Kim JH, Kim MJ, Kim Y, Kim YJ, Kim KN, Jo JK.
PMID: 43063679 [PubMed - as supplied by publisher]


Overall Survival With [(177)Lu]Lu-PSMA-617 in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Bayesian Reanalysis of the PSMAfore Trial.
JCO Clin Cancer Inform
Satapathy S, Chandekar KR.
PMID: 43063372 [PubMed - indexed for MEDLINE]


Evaluation of the efficacy and safety of particle therapy for kidney cancer through a multicenter registry study and meta-analysis.
J Radiat Res
Nishioka K, Ishikawa H, Maruo K, Kawamura H, Iizumi T, Sato H, Toyama S, Mori T, Suzuki O, Okimoto T, Ogino T, Murakami M, Tamamura H, Shibamoto Y, Umehara K, Hashimoto T, Aoyama H, Sakurai H.
PMID: 43062948 [PubMed - as supplied by publisher]


Comparative effectiveness and treatment modification of first-line apalutamide versus enzalutamide in metastatic castration-sensitive prostate cancer: a propensity score-matched multicenter study.
Jpn J Clin Oncol
Ohtani M, Narita T, Miyauchi K, Morishita S, Fujita N, Kikuchi D, Abe N, Kobayashi S, Wada N, Hatakeyama S, Numakura K.
PMID: 43062936 [PubMed - as supplied by publisher]


Concurrent bone-modifying agent use and fracture risk in patients treated with radium-223 for metastatic castration-resistant prostate cancer: A Japanese claims database study.
Ann Nucl Med
Takeda K, Umezawa R, Yamamoto T, Takahashi N, Jingu K.
PMID: 43062625 [PubMed - as supplied by publisher]


Prediction models for progression to castration-resistant prostate cancer after androgen deprivation therapy: a narrative review (2021-2026).
Front Oncol
Yuan J, Jiang Z, Chen W, Wang S.
PMID: 43061358 [PubMed]


Comparative Analysis of CNN Architectures for High-Accuracy Subtype Classification of Renal Cell Carcinoma Using CECT.
IEEE Open J Eng Med Biol
M G RK, Laju PK, Bhat V, T A, K P, H A.
PMID: 43061253 [PubMed]


Bayesian deep learning framework to address multi-rater annotation uncertainty in prostate cancer magnetic resonance imaging segmentation.
Phys Imaging Radiat Oncol
Liang X, Kabir T, Tammisetti VS, Giancardo L, Shams S.
PMID: 43061230 [PubMed]


Focal Versus Whole-Gland Cryoablation Therapy in High-Grade Prostate Cancer: A Single-Institution Retrospective Study.
Cureus
Khan A, Shawwa J, Ho A, Coletta D, Dalal A, Feloney M, Khan AU.
PMID: 43061079 [PubMed]


Association Between Prostate Volume and PI-RADS v2.1 Performance for Detecting Clinically Significant Prostate Cancer in Men in the PSA Gray Zone: A Retrospective Study.
Cancer Manag Res
Li Q, Zhao Y, Tang L, Zheng J, Li L.
PMID: 43060703 [PubMed]


Statement of Retraction: Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.
Bioengineered

PMID: 43059549 [PubMed - in process]


Glutamine metabolic reprogramming remodels the immunosuppressive microenvironment and modulates immunotherapy response in renal cell carcinoma (Review).
Oncol Rep
Liu Y, Liu W, Zhang L, Wang Y, Chai K, Ye Y.
PMID: 43059384 [PubMed - indexed for MEDLINE]


Impact of pioglitazone use on clinicopathological features and aggressiveness of bladder cancer: a retrospective cohort study.
BMC Urol
Cin H, Gülmez H, Turan T.
PMID: 43058660 [PubMed - in process]


Construction of a gene-based diagnostic model for prostate cancer and AI-guided drug prediction coupled with molecular docking.
BMC Urol
Du G, Qiu Y, Wang H, Ma H.
PMID: 43058644 [PubMed - indexed for MEDLINE]


Nonsteroidal anti-inflammatory drug use and site-specific risk of urological cancers: a systematic review and meta-analysis.
BMC Cancer
Cao S, Liu M, Wang C, Yang S, Zhang Z, Zhang W, Zhao X, Zhao Z, Hou J, Zhang J.
PMID: 43058591 [PubMed - indexed for MEDLINE]


Integrative feature-enhanced network model predicting prostate biopsy results in patients with negative MRI.
BMC Cancer
Zheng H, Miao Q, Hung A, Zhao K, Scalzo F, Raman SS, Sung K.
PMID: 43058574 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 183133    Seite 1 von 9157  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1